Saturday, August 13, 2005

Salon.com News | Big Pharma's free ride

An interesting article on the difficulties third world countries have in terms of producing generic drugs... (subscription required)

Salon.com News | Big Pharma's free ride: "Aug. 12, 2005 | In November 2004, Guatemala's Congress repealed a law that gave brand-name prescription drugs protection from generic competition. The law had allowed brand-name companies to conceal data that generic companies would use to bring their own versions to market, and public health activists hailed the move as a step toward greater access to essential medicines. But four months later, legislators reversed themselves and put those protections back in place. The protests that followed led to many injuries and one death. Why did this small nation, where cheap generic drugs have been key to treating one of Latin America's largest HIV-positive populations, change course?

In a word: CAFTA. Guatemala changed its laws in order to become part of the Central American Free Trade Agreement, which encompasses five Central American countries and the Dominican Republic. CAFTA, which President Bush signed last week after coaxing it through Congress, requires its members to adopt strict rules on intellectual property rights, including those protecting prescription drugs. These drugs cost up to 22 times what Doctors Without Borders, which runs several AIDS clinics in Guatemala, pays for generic equivalents. Some economists say similarly high drug costs would cause the unique universal healthcare system of nearby Costa Rica to collapse.

Though protections for the environment and workers' rights are often the most contentious issues surrounding trade deals such as CAFTA and NAFTA, pharmaceutical giants, aided by the U.S. government, are increasingly using these pacts to assert their power over markets in developing countries. Activists and public-health groups working on the ground say these companies put profits above public health by keeping generic medicines off the shelves, which keeps prices high and drugs out of reach to all but the most wealthy. These deals apply to all prescription drugs, but generics have been particularly effective at driving down the prices of drugs used to treat AIDS -- in some cases by 98 percent -- even as AIDS rates have skyrocketed. CAFTA is signed and delivered, and the United States is now preparing trade pacts with Thailand, South America and other parts of the developing world."...

No comments:

Related Posts with Thumbnails

ShareThis